Control What You Can
Business leader CiCi Rojas takes life lessons from lymphoma.
by Lindsey Konkel Neabore
CAR T Cells for Blood Cancer Patients
Researchers aim to minimize disease relapses by targeting multiple proteins.
by Erin O'Donnell
A Treatment That Came Just in Time
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
Searching the Blood for Signs of Altered Immunity
The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
Medicare to Cover CAR-T Cell Therapy
High cost may still limit access.
by Nancy Averett
Finding More Targets for CAR-T Cells
CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.
by Kendall K. Morgan
The Right Dose
Researchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.
by Kate Yandell
What Not to Say to a Cancer Patient
When visiting a friend or family member who is sick, it's good to leave platitudes at the door.
by Michael Gavaghen
A Lesson in Service
Rabbi Ben David was comfortable in his role of helping those in need, but he had to rely on others after his lymphoma diagnosis. The marathon runner has returned to an active life one step at a time.
by Lindsey Konkel
From the Editor-in-Chief
CAR-T Cells: ‘Bionic’ Immune Cells for Treating Cancer
T cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD